Literature DB >> 24365301

Obstructive sleep apnea and other sleep-related syndromes.

Teresa Paiva1, Hrayr Attarian2.   

Abstract

Obstructive sleep apnea syndrome (OSAS) is a common disorder characterized by repetitive episodes of breathing cessation due to complete or partial collapse of the upper airway therefore affecting ventilation. It is quite common, with a prevalence of about 2-4%, has a strong genetic component, and creates a proinflammatory state with elevated TNFα and other cytokines. If untreated, OSA can lead to significant neurological problems that include stroke, cognitive decline, depression, headaches, peripheral neuropathy, and nonarteritic ischemic optic neuropathy (NAION). Treatment reverses some of these neurological problems. Treatment includes continuous positive airway pressure and its variants, oral appliances, weight loss, upper airway surgery, and rarely maxillofacial procedures. Other sleep breathing disorders such as hypoventilation, central sleep apnea, complex sleep apnea, and Cheyne-Stokes respiration are less common and are sometimes associated with neuromuscular disorders causing diaphragmatic paralysis, but can also be seen in opiate exposure and severe obesity.
© 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Obstructive sleep apnea; central sleep apnea; cognition; comorbidities; health risks; hypoventilation syndromes

Mesh:

Year:  2014        PMID: 24365301     DOI: 10.1016/B978-0-7020-4086-3.00018-7

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  9 in total

1.  Evaluation of an oral appliance in patients with mild to moderate obstructive sleep apnea syndrome intolerant to continuous positive airway pressure use: Preliminary results.

Authors:  S Cantore; A Ballini; D Farronato; G Malcangi; G Dipalma; F Assandri; U Garagiola; F Inchingolo; D De Vito; N Cirulli
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

2.  Peripheral blood oxidative stress markers for obstructive sleep apnea-a meta-analysis.

Authors:  Yuzhui Hu; Lin Mai; Jingying Luo; Wensong Shi; Hui Xiang; Sijia Song; Liuyan Hong; Wenting Long; Biwen Mo; Miao Luo
Journal:  Sleep Breath       Date:  2022-01-03       Impact factor: 2.816

Review 3.  Arrhythmogenic mechanisms of obstructive sleep apnea in heart failure patients.

Authors:  Karan R Chadda; Ibrahim T Fazmin; Shiraz Ahmad; Haseeb Valli; Charlotte E Edling; Christopher L-H Huang; Kamalan Jeevaratnam
Journal:  Sleep       Date:  2018-09-01       Impact factor: 5.849

Review 4.  The efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions.

Authors:  Lucilia N Diogo; Emília C Monteiro
Journal:  Front Physiol       Date:  2014-09-22       Impact factor: 4.566

5.  Distinct associations between hypertension and obstructive sleep apnea in male and female patients.

Authors:  Qiang Yu; Guizhi Yin; Peng Zhang; Zhiping Song; Yueguang Chen; Dadong Zhang; Wei Hu
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

Review 6.  Cognitive deficits in adults with obstructive sleep apnea compared to children and adolescents.

Authors:  Krzysztof Krysta; Agnieszka Bratek; Karolina Zawada; Radosław Stepańczak
Journal:  J Neural Transm (Vienna)       Date:  2016-01-04       Impact factor: 3.575

7.  Obstructive sleep apnea and severity of coronary artery disease.

Authors:  Ali Vasheghani-Farahani; Fatemeh Kazemnejad; Khosro Sadeghniiat-Haghighi; Soleil Saadat; Parya Tavakolipoor; Tahereh Yazdani; Mohammad Alidoosti; Vahid Ghasem-Amooeian; Haleh Ashraf
Journal:  Caspian J Intern Med       Date:  2018

8.  Intermittent hypoxia-induced rat pancreatic β-cell apoptosis and protective effects of antioxidant intervention.

Authors:  Y Fang; Q Zhang; J Tan; L Li; X An; P Lei
Journal:  Nutr Diabetes       Date:  2014-09-01       Impact factor: 5.097

9.  Management of severe sleep apnea secondary to juvenile arthritis with temporomandibular joint replacement and mandibular advancement.

Authors:  S Arun Paul; S Sibu Simon; Barney Issac; Saurav Kumar
Journal:  J Pharm Bioallied Sci       Date:  2015-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.